Sociedad Química y Minera de Chile S.A. · SQM · FY2026 Q3 · Calendar Q4 2026
SQM Sees Lithium Demand Growth but Flags Price and Inventory Risks
SQM’s account of the quarter pairs improved profitability and expected lithium-demand growth with current price weakness and uncertainty about inventories. The outlook depends on whether demand and production ramp-ups can offset pricing, fertilizer-volume and execution pressures.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about SQM FY2026 Q3
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Compared with the prior quarter’s record lithium sales and higher-price tailwind, the current-quarter analysis puts more emphasis on lithium price weakness, China inventory levels and a downward revision to plant-nutrition volume expectations. Management maintained its capex schedule and described production expansion plans as on track.
Guidance delta
Management’s guidance sentiment was maintained. The transcript analysis says the capex schedule is unchanged despite lower spending to date, while plant-nutrition volume expectations were revised down because of higher fertilizer prices.
Key takeaways
- Management described a strong quarter and substantially higher year-to-date net income, while acknowledging weak lithium pricing.
- The company expects lithium demand to grow, supported by EV adoption, battery storage and rising lithium content per vehicle.
- Higher fertilizer prices weighed on plant-nutrition volume expectations; lithium inventories, especially in China, remain a key uncertainty.
Management priorities
- Ramp lithium production at Novandino and Mount Holland and expand lithium-hydroxide output.
- Continue efficiency and recovery improvements at Novandino and maintain the capital-expenditure schedule.
- Evaluate additional potash capacity while developing lithium-related operations in Chile and China.
Follow SQM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Neutral | Upgrade | Nov 6, 2026 |
| Citigroup | Buy | Neutral | Upgrade | Aug 27, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Aug 24, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 15, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 14, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Mar 25, 2026 |
| Jefferies | Hold | Buy | Downgrade | Oct 6, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 21, 2025 |
| Loop Capital | Hold | Hold | Maintain | Aug 28, 2023 |
| HSBC | Buy | Buy | Maintain | Jul 6, 2023 |
| Morgan Stanley | Underweight | Equal Weight | Downgrade | Mar 31, 2022 |
| Santander | Hold | Buy | Downgrade | Apr 3, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Mar 8, 2019 |
| Miller Tabak | Hold | Neutral | Maintain | Jul 2, 2013 |
| Craig-Hallum | Hold | Buy | Downgrade | May 21, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $46.97. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| J.P. Morgan | Lucas Ferreira | $71 | $57.52 | +51.2% | Nov 6, 2026 |
| BMO Capital | Analyst unavailable | $90 | $66.45 | +91.6% | Oct 6, 2026 |
| Scotiabank | Ben Isaacson | $104 | $81.96 | +121.4% | Aug 24, 2026 |
| Deutsche Bank | Analyst unavailable | $94 | $77.36 | +100.1% | Aug 20, 2026 |
| Scotiabank | Analyst unavailable | $93 | $67.16 | +98.0% | Jul 28, 2026 |
| Goldman Sachs | Marcio Farid | $82 | $72.95 | +74.6% | Jul 15, 2026 |
| Deutsche Bank | Analyst unavailable | $98 | $71.94 | +108.6% | Jul 14, 2026 |
| Goldman Sachs | Analyst unavailable | $100 | $83.42 | +112.9% | Jun 2, 2026 |
| Scotiabank | Ben Isaacson | $105 | $84.18 | +123.5% | May 28, 2026 |
| Deutsche Bank | Analyst unavailable | $106 | $89.75 | +125.7% | May 5, 2026 |
| Berenberg Bank | Analyst unavailable | $53 | $71.86 | +12.8% | Feb 23, 2026 |
| Deutsche Bank | Corinne Blanchard | $91 | $81.88 | +93.7% | Jan 21, 2026 |
| Deutsche Bank | Analyst unavailable | $88 | $77.76 | +87.4% | Jan 12, 2026 |
| Scotiabank | Analyst unavailable | $90 | $77.71 | +91.6% | Jan 12, 2026 |
| UBS | Analyst unavailable | $79 | $64.17 | +68.2% | Dec 17, 2025 |
| Goldman Sachs | Analyst unavailable | $63 | $63.06 | +34.1% | Dec 4, 2025 |
| Scotiabank | Ben Isaacson | $80 | $58.26 | +70.3% | Nov 24, 2025 |
| BMO Capital | Analyst unavailable | $77 | $62.62 | +63.9% | Nov 20, 2025 |
| Deutsche Bank | Corinne Blanchard | $46 | $44.44 | -2.1% | Oct 17, 2025 |
| Jefferies | Alejandro Anibal Demichelis | $50 | $43.11 | +6.5% | Oct 6, 2025 |
| BMO Capital | Joel Jackson | $55 | $37.12 | +17.1% | Aug 28, 2024 |
| Jefferies | Alejandro Demichelis | $55 | $38.64 | +17.1% | Aug 26, 2024 |
| Bank of America Securities | Isabella Simonato | $38 | $37.7 | -19.1% | Aug 21, 2024 |
| Goldman Sachs | Marcio Farid | $46.5 | $35.98 | -1.0% | Aug 9, 2024 |
| Berenberg Bank | Andres Castanos-Mollor | $35 | $37.73 | -25.5% | Jul 31, 2024 |
| BMO Capital | Joel Jackson | $65 | $46.52 | +38.4% | Jun 3, 2024 |
| Deutsche Bank | Corinne Blanchard | $45 | $49.84 | -4.2% | May 28, 2024 |
| Deutsche Bank | Corinne Blanchard | $42 | $49.72 | -10.6% | May 23, 2024 |
| Jefferies | Alejandro Demichelis | $62.8 | $47.61 | +33.7% | Apr 8, 2024 |
| Deutsche Bank | Corinne Blanchard | $115 | $90.07 | +144.8% | Aug 22, 2022 |
Track every rating change on SQM the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationSociedad Química y Minera de Chile S.A. (SQM) specializes in the production and global distribution of a diverse range of items, including advanced plant nutrients, various iodine and lithium derivatives, potassium chloride, potassium sulfate, and a selection of industrial chemicals. Its specialized plant nutrition offerings feature compounds like potassium nitrate, sodium nitrate, sodium potassium nitrate, custom fertilizer blends, and other high-performance fertilizers. Iodine and its compounds are supplied for a broad spectrum of uses across medical, pharmaceutical, agricultural, and industrial fields; these applications encompass x-ray contrast media, polarizing films for LCD and LED screens, antiseptics, biocides, disinfectants, pharmaceutical synthesis, electronic components, pigments, and dye constituents.…
Historical context
All SQM earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTA-PA EIDP, Inc. | FY2026 Q3 · Calendar Q3 2026 | +232.7% | — | New-product growth cushions EIDP, but Brazil weakness drives a lower outlook |
| CTA-PB EIDP, Inc. USD 4.50 Cum Pfd Registered Shs | FY2026 Q3 · Calendar Q3 2026 | — | — | New-product growth held up, but Brazil weakness cut the EBITDA outlook |
| VYLR Vylor Inc. | FY2026 Q3 · Calendar Q4 2026 | +21.1% | -0.1% | Vylor reaffirms 2026 outlook as Brazil licensing model shifts |
| CTVA Corteva, Inc. | FY2026 Q3 · Calendar Q4 2026 | +231.9% | -19.6% | Corteva Q3: New Products Grow as Brazil Weakness Cuts Outlook |
| FNV Franco-Nevada Corporation | FY2026 Q3 · Calendar Q4 2026 | +6.8% | -2.4% | Franco-Nevada Q3: stronger earnings, but revenue missed estimates |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPFY2026 Q3 · November 16, 2026-3.0% EPS-2.5% move
- XPEVFY2026 Q3 · November 16, 2026-26.5% EPS+3.2% move
Get the SQM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-18T19:17:07.289706+00:00
- FN2 earnings calendar · 2026-11-19T01:23:16.862628+00:00
- Polygon adjusted daily market bars · 2026-11-19T07:40:45.677270+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-19T07:40:45.674240+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-19. For educational purposes only; not investment advice.